Clinical Trial Update: A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the combination of afatinib and palbociclib in previously treated advanced esophageal squamous cell carcinoma is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Gilotrif (Afatinib)
• IBRANCE (PALBOCICLIB)

Snippet

Sponsor: West China Hospital | Conditions: Esophagus Cancer | Phase 1, Phase 2 | Status: RECRUITING